KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Return on Capital Employed (2019 - 2026)

Castle Biosciences' Return on Capital Employed history spans 7 years, with the latest figure at 8.53% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 1036.0% to 8.53% in Q4 2025 year-over-year; TTM through Dec 2025 was 8.53%, a 1036.0% decrease, with the full-year FY2025 number at 8.8%, down 1076.0% from a year prior.
  • Return on Capital Employed hit 8.53% in Q4 2025 for Castle Biosciences, down from 7.01% in the prior quarter.
  • Over the last five years, Return on Capital Employed for CSTL hit a ceiling of 1.83% in Q4 2024 and a floor of 24.73% in Q2 2023.
  • Historically, Return on Capital Employed has averaged 10.13% across 5 years, with a median of 9.0% in 2021.
  • Biggest five-year swings in Return on Capital Employed: plummeted -1175bps in 2022 and later skyrocketed 2136bps in 2024.
  • Tracing CSTL's Return on Capital Employed over 5 years: stood at 9.47% in 2021, then crashed by -85bps to 17.49% in 2022, then grew by 2bps to 17.12% in 2023, then soared by 111bps to 1.83% in 2024, then plummeted by -566bps to 8.53% in 2025.
  • Business Quant data shows Return on Capital Employed for CSTL at 8.53% in Q4 2025, 7.01% in Q3 2025, and 4.88% in Q2 2025.